Economic burden of patients living with heart disease in the last years of life in Australia: a retrospective analysis using linked data

被引:2
|
作者
Kularatna, Sanjeewa [1 ]
Senanayake, Sameera [1 ]
Parsonage, William [1 ,2 ]
Jun, Deokhoon [3 ]
McPhail, Steven [1 ,4 ]
机构
[1] Queensland Univ Technol QUT, Fac Hlth, Australian Ctr Hlth Serv Innovat & Ctr Healthcare, Sch Publ Hlth & Social Work, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia
[2] Metro North Hlth, Royal Brisbane & Womens Hosp, Herston, Qld 4059, Australia
[3] Metro South Hlth, Clin Informat Directorate, Brisbane, Qld, Australia
[4] Metro South Hlth, Clin Informat, Brisbane, Qld, Australia
关键词
Heart disease; Hospital costs; End of life care; OF-LIFE; MULTIMORBIDITY; CANCER; CARE; END;
D O I
10.1093/ehjqcco/qcab006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims People living with heart disease are at elevated risk of hospitalization during the last years of their life. The aim of this study was to describe hospitalization-related usage patterns, and associated cost burden, for patients living with heart disease in the last 6 years of their life. Methods and results The study was an observational cohort study, using routinely collected and linked data from hospital admission (HA), emergency department (ED) presentation and death registry data in Queensland, Australia. The study sample included 1000 randomly selected patients who died in 2017 due to any cause who had been living with heart disease for at Least the prior 6 years. The two main outcomes of interest in this study were cost of HAs and cost of ED presentation in the Last 6 years before death. Total cost was calculated as a sum of direct and overhead costs from each of the hospital presentations. The mean HA per patient in the sixth year, second year, and last year prior to death was 5.3, 6.6, and 7.5, respectively, with a similar pattern observed for ED presentations. The associated costs per patient from HA followed a similar trajectory increasing gradually from $17 711 in the sixth year to $26 658 in the second last year prior to death. A similar pattern was observed for ED presentation costs. Conclusion The large increase cost in the last year of life was primarily attributable to higher treatment cost per HA at end of life.
引用
收藏
页码:333 / 341
页数:9
相关论文
共 50 条
  • [1] Economic burden of patients living with heart disease in the last years of life in Australia: a retrospective analysis using linked data (vol 8, pg 333, 2022)
    Kularatna, Sanjeewa
    Senanayake, Sameera
    Parsonage, William
    Jun, Deokhoon
    McPhail, Steven
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2023, 9 (03) : 303 - 303
  • [2] Rheumatic Heart Disease outcomes in Australia: a linked data analysis
    Stacey, Ingrid
    Bond-Smith, Daniela
    Seth, Rebecca
    Cannon, Jeffrey
    Murray, Kevin
    Ralph, Anna
    Carapetis, Jonathan
    Hung, Joe
    Katzenellenbogen, Judith
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50 : 223 - 223
  • [3] The annual economic burden incurred by heart failure patients in Vietnam: a retrospective analysis
    Dao, Tien Duc
    Tran, Hien Thi Bich
    Vu, Quynh Van
    Nguyen, Huong Thi Thanh
    Nguyen, Pol Van
    Vo, Trung Quang
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2024, 17 (01)
  • [4] Hospital-service use in the last year of life by patients aged >60 years who died of heart failure or cardiomyopathy: A retrospective linked data study
    Singh, Gursharan K.
    Bowers, Alison P.
    Ferguson, Caleb
    Ivynian, Serra E.
    Chambers, Shirley
    Davidson, Patricia M.
    Hickman, Louise D.
    PALLIATIVE MEDICINE, 2023, 37 (08) : 1232 - 1240
  • [5] The Economic Burden of Congenital Cytomegalovirus Disease in the First Year of Life: A Retrospective Analysis of Health Insurance Claims Data in the United States
    Meyers, Juliana
    Sinha, Anushua
    Samant, Salome
    Candrilli, Sean
    CLINICAL THERAPEUTICS, 2019, 41 (06) : 1040 - 1056
  • [6] RETROSPECTIVE ANALYSIS OF THE ECONOMIC BURDEN OF PATIENTS DIAGNOSED WITH CONGESTIVE HEART FAILURE IN THE CALIFORNIA MEDICAID POPULATION
    Ogbomo, A.
    Zhao, Y.
    Kariburyo, M. F.
    Xie, L.
    Yuce, H.
    Baser, O.
    VALUE IN HEALTH, 2016, 19 (03) : A46 - A46
  • [7] A RETROSPECTIVE ANALYSIS OF THE ECONOMIC BURDEN AMONG PATIENTS DIAGNOSED WITH CHRONIC MIGRAINE USING THE VETERANS HEALTH ADMINISTRATION MEDICAL DATA
    Mao, X.
    Shrestha, S.
    Baser, O.
    Wang, L.
    VALUE IN HEALTH, 2015, 18 (03) : A282 - A282
  • [8] RETROSPECTIVE ANALYSIS OF THE ECONOMIC BURDEN AMONG CUSHING'S DISEASE PATIENTS IN THE US MEDICAID PROGRAM
    Li, L.
    Shrestha, S.
    Baser, O.
    Wang, L.
    VALUE IN HEALTH, 2014, 17 (07) : A350 - A350
  • [9] Financial Costs of Emergency Department Presentations for Australian Patients With Heart Disease in the Last 3 Years of Life
    Kularatna, Sanjeewa
    Wong, Jessie
    Senanayake, Sameera
    Brain, David
    Greenslade, Jaimi
    Parsonage, William
    Jun, Deokhoon
    McPhail, Steven
    HEALTH SERVICES INSIGHTS, 2022, 15
  • [10] The health services burden of heart failure: an analysis using linked population health data-sets
    Jane Robertson
    Patrick McElduff
    Sallie-Anne Pearson
    David A Henry
    Kerry J Inder
    John R Attia
    BMC Health Services Research, 12